Related references
Note: Only part of the references are listed.Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b-4 CKD
Pablo E. Pergola et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1
Qing Qing Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Transcriptional Regulation of Renal Cytoprotective Genes by Nrf2 and Its Potential Use as a Therapeutic Target to Mitigate Cisplatin-Induced Nephrotoxicity
Lauren M. Aleksunes et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Albuminuria: A target for treatment of type 2 diabetic nephropathy
Dick de Zeeuw
SEMINARS IN NEPHROLOGY (2007)
Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005
P Rossing
DIABETOLOGIA (2006)
Share Paper
